• Explore /
  • Poster
  • / Pilot SCAT trial: Spanish customized adjuvant chemotherapy (CT) based on BRCA1 mRNA expression levels (l) in resected stage II-IIIA non-small cell lung cancer (NSCLC) patients (p).

Pilot SCAT trial: Spanish customized adjuvant chemotherapy (CT) based on BRCA1 mRNA expression levels (l) in resected stage II-IIIA non-small cell lung cancer (NSCLC) patients (p).

Abstract Poster

Authors

null

Jose Miguel Sanchez

Hospital M. D. Anderson Internacional, Madrid, Spain

Jose Miguel Sanchez , Manuel Cobo , Rafael Arrabal , Bartomeu Massuti , Jose Manuel Rodriguez Paniagua , Teresa Moran , Julio Astudillo , Ulpiano Jimenez , Yat Wa Pun , David Aguiar Bujanda III, Jorge Freixenet , Jose-Luis Gonzalez-Larriba , Florentino Hernando-Trancho , Jose Gómez-Codina , Juan-Carlos Penalver , Natividad Martinez Banaclocha , Guillermo Lopez-Vivanco , Joaquin Pac , Miquel Taron , Rafael Rosell

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2012 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Lung Cancer - Non-small Cell Local-regional/Small Cell/Other Thoracic Cancers

Track

Lung Cancer

Sub Track

Adjuvant Therapy

Citation

J Clin Oncol 30, 2012 (suppl; abstr 7011)

DOI

10.1200/jco.2012.30.15_suppl.7011

Abstract #

7011

Poster Bd #

3

Abstract Disclosures

Similar Posters

First Author: B. Massuti

First Author: Fatemeh Ardeshir-Larijani

Poster

2020 ASCO Virtual Scientific Program

Role of adjuvant chemotherapy in patients with pathological stage I NSCLC with high-risk features.

Role of adjuvant chemotherapy in patients with pathological stage I NSCLC with high-risk features.

First Author: Lubina Arjyal

First Author: Heather A. Wakelee